Delivery Order SPE2DB20D2002-SPE2DB22FL53Y

Award Date 7/15/22
Potential Completion Date 7/18/22
Potential Value $7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,032.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BROMSITE 0.075% EYE DROPS 5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of June 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
This federal contract award with a ceiling value of $4,421.74 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of BROMSITE 0.075% eye drops in 5 milliliter bottles, to be delivered by March 16, 2023. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract has a ceiling value of $2,830.99 and an ultimate completion date of November 16, 2021. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,498.63 fixed-price delivery order is for the supply of BROMSITE 0.075% eye drops, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,818.65, is for the delivery of Bromsite 0.075% eye drops in 5ml vials. The contract is a Firm Fixed Price Delivery Order with a completion date of September 18, 2023. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BROMSITE 0.075% eye drops in 5mL bottles, with a ceiling value of $7,789.71 and a completion date of August 17, 2023. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The $6,604.74 firm fixed-price delivery order has a completion date of November 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract, valued at $3,547.25, is a firm fixed-price delivery order with a completion date of December 11, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the procurement of BROMSITE 0.075% eye drops, with a ceiling value of $4,466.70. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,577.96 firm fixed-price delivery order is for the supply of 4556402973 - BROMSITE 0.075% EYE DROPS 5ML. The contract has a completion date of March 1, 2022 and was awarded on February 28, 2022. No set-aside designation was used for this open competition contract. Amerisourcebergen Drug Corp is a subsidiary of...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB22FL53Y
    Delivery Order

This federal contract award is for the delivery of 4557802497 BROMSITE 0.075% EYE DROPS 5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award has a ceiling value of $7,037.99 and an ultimate completion date of July 18, 2022.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:07 AM